Related Experiment Video
Updated: Mar 15, 2026

06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
13.0K
Cell Therapy Products in Menopausal Medicine
Hye Ji Choi1, Tae-Hee Kim2, Soo Ah Kim3
1Department of Life Science and Biotechnology, Soonchunhyang University College of Natural Sciences, Asan, Korea.
Journal of Menopausal Medicine
|September 13, 2016
Summary
This review highlights cell therapy products as a promising treatment for postmenopausal osteoporosis. Further research is vital to improve outcomes for postmenopausal women.
Area of Science:
- Biomedical research
- Gerontology
- Cellular biology
Background:
- Postmenopausal diseases, including osteoporosis, increase with age.
- Osteoporosis significantly impacts postmenopausal women's health.
- Current treatments have limitations, necessitating novel therapeutic approaches.
Purpose of the Study:
- To introduce cell therapy products as a new treatment for postmenopausal osteoporosis.
- To explore current research trends in cell therapy for this condition.
- To emphasize the importance of this research for both scientists and patients.
Main Methods:
- Literature review of existing research on cell therapy for osteoporosis.
- Analysis of current and historical medications used for postmenopausal osteoporosis.
- Examination of technological advancements and challenges in cell therapy.
Main Results:
- Cell therapy products represent a novel therapeutic avenue for postmenopausal osteoporosis.
- Significant research efforts are underway to develop and refine these treatments.
- Existing technologies face developmental and technical hurdles.
Conclusions:
- Cell therapy holds considerable promise for improving the management of postmenopausal osteoporosis.
- Continued research and technological advancement are crucial for realizing the full potential of cell therapy.
- Addressing current challenges will enhance treatment efficacy and patient outcomes.
More Related Videos
Related Concept Videos
Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Hormonal Regulation of the Menstrual Cycle
2.1K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.1K
Mesenchymal Stem Cells
5.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.8K
Hormonal Regulation
36.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.7K
Hormonal Regulation
49.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
49.4K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K

